A head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in ...

For the first time, scientists have pitted the two most popular weight loss drugs against each other in a direct competition ...

Retatrutide and Tirzepatide represent promising peptides with potential implications in regulating metabolic functions. Their distinct mechanisms of action and possible properties in glycemic ...

As the popularity of peptides continues to rise in 2025, fueled by the success of GLP-1 medications like Semaglutide and Tirzepatide, more individuals are exploring their potential health benefits ...

Drugs like Wegovy (semaglutide), Saxenda (liraglutide), and Zepbound (tirzepatide) mimic the peptides in your body to reduce appetite and control cravings. Proteins are made up of smaller units ...

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the ...